BioLamina

Recent Finacing

Equity

Recent Raise

$18.2M

BioLamina is a Swedish biotech company that specializes in developing and producing recombinant human laminins, key proteins used for growing and manipulating stem cells and primary cells, to support the production of stem cell-derived therapeutics and advanced cell-based disease models.